China has accused GlaxoSmithKline of being at the centre of a “huge” scheme to raise drug prices in three of the country’s biggest cities and said the UK-based drugmaker’s staff had confessed to bribing government officials and doctors.
manbetx3.0 指控葛兰素史克(GlaxoSmithKline, GSK)在manbetx3.0 三个大城市为抬高药价而“大肆行贿”，并称这家总部位于英国的制药商的员工已承认向政府官员和医生行贿。
您已阅读7%（319字），剩余93%（3976字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。